Diagnostic value of cellular inflammatory markers in CNS tumor patients undergoing glucocorticoid therapy
For patients with glioblastoma, the LMR serves as a diagnostically significant inflammatory biomarker independent of glucocorticoid administration. In patients with metastatic brain lesions, the most significant diagnostic value was demonstrated by monocyte counts, PIV and LMR.
Authors
- Maxim Alekseevich Shevtsov (ORCID: https://orcid.org/0000-0002-8539-2239)
- Daria Sitovskaya
- Victor E. Olyushin
- Alexei Ulitin
- Nataliya Dryagina
- Sofia Sklyar
- Konstantin Samochernykh
- Stephanie E. Combs
Institutions
- Federal Almazov North-West Medical Research Centre (RU)
- Institute of Cytology (RU)
- Russian Scientific Research Neurosurgical Institute (RU)
- Technical University of Munich (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-18
- DOI
- https://doi.org/10.3389/fonc.2026.1764339
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Technische Universität München